| Literature DB >> 25359085 |
Lise Lund Håheim, Jon Helgeland.
Abstract
BACKGROUND: Norway introduced 32 priority guidelines for elective health treatment in the specialist health service in the period 2008-9. The guidelines were intended to reduce large differences in waiting times among hospitals, streamline referrals and ensure that patients accessed the necessary healthcare to which they were entitled for certain conditions. Referral information guided the priorities. As the referral information was key to future evaluation of the guidelines, this study validates the referral information in hospital patient records against discharge diagnoses, because only the discharge diagnosis is recorded in the Norwegian Patient Register (NPR) database, which is used in the main evaluation.Entities:
Mesh:
Year: 2014 PMID: 25359085 PMCID: PMC4219032 DOI: 10.1186/s12913-014-0493-5
Source DB: PubMed Journal: BMC Health Serv Res ISSN: 1472-6963 Impact factor: 2.655
Priority guidelines, diagnoses/conditions and the ICD-10 codes for the validation study
|
|
|
|
|---|---|---|
| Oncology | Morbidity after cancer treatment | Z08 |
| Brain metastases | C79.3 | |
| Oral surgery and oral medicine | Facial pain | G50, G51 |
| Jaw infections | K10, K04 | |
| Geriatrics | Sequel after stroke | I69.1, I69.3, I69.4 |
| Complex cognitive reduction | F00, F01, F03, F04, F05, F06.7, R41.8 | |
| Women’s diseases | Ovarian cancer | C56 |
| Descensus uteri | N81 | |
| Urology | Haematuria | N02, R31, Z03.1, Z03.8 |
| Kidney or ureter stone | N20, N22, N23 | |
| Lung disorders | Chronic obstructive pulmonary disease (stages 3 and 4) | J44, J44.0, J44.1, J44.8, J44.9 |
| Sleep apnoea | G47.3 | |
| Heart disease | Coronary heart disease (angina pectoris) | I20, I25 |
| Heart valve disorder | I27, I28, I34, I35, I36, I37, I38, I39 | |
| Skin disorders | Leg and foot wounds | L97 |
| Psoriasis: serious or moderate | L40 | |
| Mental health of children and young people | Eating disorder | F50 |
| Serious concern of mental disorder and behavioural disorder | Z13.3 | |
| Orthopaedics | Metastasis to muscles and skeleton | C79.5 |
| Hip osteoarthritis | M16 |
Number of medical records examined, gender and age (years) of patients per condition or disease
|
|
|
|
| ||
|---|---|---|---|---|---|
|
|
|
|
| ||
| 1. Eating disorder | 60 | 58 (97) | 2 (3) | 21 (19–28) | 29 (17–41) |
| 2. Serious concern of mental disorder and behavioural disorder | 9 | 6 (67) | 3 (33) | 14 (11–18) | 17 (10–20) |
| 3. Sleep apnoea | 100 | 24 (24) | 76 (76) | 55 (33–61) | 50 (40–60) |
| 4. Chronic obstructive pulmonary disease (stages 3 and 4) | 99 | 53 (545) | 46 (47) | 69 (64–78) | 71 (64–78) |
| 5. Ovarian cancer | 100 | 100 (100) | − | 65 (55–72) | − |
| 6. Descensus uteri | 100 | 100 (100) | − | 64 (54–73) | − |
| 7. Kidney or ureter stone | 100 | 50 (50) | 50 (50) | 54 (38–66) | 60 (51–74) |
| 8. Haematuria | 100 | 48 (48) | 52 (52) | 59 (46–68) | 61 (41–72) |
| 9. Hip osteoarthritis | 100 | 69 (69) | 31 (31) | 69 (60–77) | 63 (56–73) |
| 10. Metastasis to muscles and skeleton | 100 | 39 (39) | 61 (61) | 63 (56–68) | 61 (60–80) |
| 11. Brain metastases | 100 | 43 (43) | 57 (57) | 63 (53–73) | 67 (59–73) |
| 12. Morbidity after cancer treatment | 100 | 44 (44) | 56 (56) | 59 (42–74) | 64 (53–69) |
| 13. Leg and foot wounds | 100 | 47 (47 | 53 (53) | 80 (71–85) | 66 (53–78) |
| 14. Psoriasis: serious or moderate | 90 | 40 (44) | 50 (56) | 47 (30–60) | 56 (45–62) |
| 15. Jaw infections | 95 | 49 (52) | 46 (48) | 45 (31–67) | 48 (27–62) |
| 16. Facial pain | 100 | 60 (60) | 40 (40) | 51 (38–65) | 53 (39–65) |
| 17. Sequel after stroke | 100 | 38 (38) | 62 (62) | 69 (56–83) | 67 (54–78) |
| 18. Complex cognitive reduction | 100 | 47 (47) | 53 (53) | 68 (60–79) | 67 (61–72) |
| 19. Coronary heart disease (angina pectoris) | 101 | 39 (39) | 62 (61) | 65 (48–76) | 65 (58–79) |
| 20. Heart valve disorder | 100 | 46 (46.0) | 54 (54.0) | 74 (62–81) | 72 (61–80) |
|
|
|
|
|
|
|
Sensitivity of the referral text or referral diagnosis versus discharge diagnosis
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
| |
| 1. Eating disorder | 0 | − | 10 | 1.00 | 25 | 25 | 1.00 | 60 | 1.00 | − | |
| 2. Serious concern mental disorder and behavioural disorder | 0 | − | − | − | − | − | 9 | 1.00 | 9 | 1.00 | − |
| 3. Sleep apnoea | 25 | 1.00 | 25 | 0.96 | 25 | 1.00 | 25 | 0.96 | 100 | 0.98 | 0.97–0.99 |
| 4. Chronic obstructive pulmonary disease | 24 | 0.88 | 25 | 0.92 | 25 | 0.92 | 25 | 0.92 | 99 | 0.91 | 0.88–0.94 |
| 5. Ovarian cancer | 25 | 0.92 | 25 | 1.00 | 25 | 0.96 | 25 | 1.00 | 100 | 0.97 | 0.95–0.99 |
| 6. Descensus uteri | 25 | 0.88 | 25 | 0.96 | 25 | 1.00 | 25 | 1.00 | 100 | 0.96 | 0.94–0.98 |
| 7. Kidney or ureter stone | 25 | 0.92 | 25 | 1.00 | 25 | 1.00 | 25 | 0.96 | 100 | 0.97 | 0.95–0.99 |
| 8. Haematuriaa | 25 | 0.08 | 25 | 0.96 | 25 | 1.00 | 25 | 0.92 | 100 | 0.87 | 0.84–0.90 |
| 9. Hip osteoarthritis | 25 | 0.88 | 25 | 0.96 | 25 | 0.92 | 25 | 0.68 | 100 | 0.85 | 0.81–0.89 |
| 10. Metastasis to muscles and skeleton | 25 | 1.00 | 25 | 1.00 | 25 | 1.00 | 25 | 0.96 | 100 | 0.99 | 0.97–1.00 |
| 11. Brain metastases | 25 | 1.00 | 25 | 0.96 | 25 | 1.00 | 25 | 1.00 | 100 | 0.99 | 0.97–1.00 |
| 12. Morbidity after cancer treatment | 25 | 0.96 | 25 | 0.96 | 25 | 1.00 | 25 | 0.96 | 100 | 0.97 | 0.95–0.99 |
| 13. Leg and foot wounds | 25 | 1.00 | 25 | 0.92 | 25 | 1.00 | 25 | 0.96 | 100 | 0.92 | 0.89–0.95 |
| 14. Psoriasis: serious or moderate | 25 | 0.92 | 25 | 0.88 | 25 | 0.96 | 15 | 0.60 | 90 | 0.87 | 0.84–0.91 |
| 15. Jaw infections | 25 | 0.96 | 25 | 0.99 | 25 | 1.00 | 20 | 0.60 | 95 | 0.88 | 0.85–0.91 |
| 16. Facial pain | 25 | 0.92 | 25 | 0.96 | 25 | 1.00 | 25 | 0.96 | 100 | 0.96 | 0.94–0.98 |
| 17. Sequel after stroke | 25 | 0.92 | 25 | 1.00 | 25 | 1.00 | 25 | 0.96 | 100 | 0.96 | 0.94–0.98 |
| 18. Complex cognitive reduction | 25 | 0.96 | 25 | 1.00 | 25 | 0.92 | 25 | 0.88 | 100 | 0.94 | 0.92–0.96 |
| 19. Coronary heart disease (angina pectoris) | 26 | 0.92 | 25 | 1.00 | 25 | 0.88 | 25 | 0.92 | 100 | 0.93 | 0.88–0.99 |
| 20. Heart valve disorder | 25 | 0.76 | 25 | 0.97 | 25 | 1.00 | 25 | 1.00 | 100 | 0.94 | 0.92–0.96 |
|
|
|
|
|
|
|
|
|
|
|
|
|
aHaematuria at Haukeland: the two codes used did not identify the cases and the result was discarded. These codes were not used in the other hospitals. The total number of medical records reviewed was 1854, but 25 were discarded.
AHUS, Akershus University Hospital; CI, confidence interval; UNN, University Hospital of North Norway in Tromsø.
The agreement or sensitivity for referral codes or text versus discharge diagnoses
|
|
| ||||
|---|---|---|---|---|---|
|
|
|
|
|
| |
| 1. Clear agreement between referral and discharge | 335 (74.4) | 386 (83.9) | 425 (89.5) | 415 (88.5) | 1561 (84.2) |
| 2. Poorly formulated referral; some modification by the hospital | 48 (10.7) | 19 (4.1) | 3 (0.6) | 15 (3.3) | 85 (4.6) |
| 3. Not sufficiently specific but adequate | 14 (3.1) | 38 (8.3) | 25 (5.3) | 0 (0) | 77 (4.2) |
| Good agreement: sum of codes 1–3 | 397 (88.2) | 443 (96.3) | 453 (95.4) | 430 (91.7 | 1723 (92.9) |
| 4. No agreement | 53 (11.8) | 17 (3.7) | 22 (4.6) | 39 (8.3) | 131 (7.1) |
| Total number of records assessed | 450 (100) | 460 (100) | 475 (100) | 469 (100) | 1854 (100) |
| Sensitivitya | 0.88 | 0.96 | 0.95 | 0.92 | 0.93 |
| 95% confidence interval | 0.87–0.90 | 0.94–0.98 | 0.91–0.99 | 0.90–0.94 | 0.92–0.94 |
aThe codes 1–3 are valid diagnoses and code 4 is a non-valid diagnosis.
Range of values: 0–1.00; study period 2008–9. χ tests overall 2008, 2009, 2008–9, and between hospitals 2008–9 – all p <0.01.
AHUS, Akershus University Hospital; UNN, University Hospital of North Norway in Tromsø.